Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHILL Pilot Study
NCT03376854Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2018
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS) (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Targeted temperature compliance at Day 3. Planned start May 2018; status: withdrawn.
02
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03376854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03376854.